HPV16 E7 (86-93) HLA-A2-restricted HPV type 16 E7 peptide.
HPV16 E7 86-93 is a synthetic peptide fragment derived from the E7 oncoprotein of human papillomavirus type 16, specifically encompassing amino acids 86 to 93 of the protein sequence. As a well-characterized epitope, it is frequently utilized in the context of viral oncology research, immunology, and cellular biology to investigate the molecular mechanisms underlying HPV-mediated cellular transformation. The sequence's high degree of conservation and immunological relevance make it an important reagent for studies focused on viral pathogenesis, host immune response, and the development of experimental immunotherapeutics. Its defined structure and established role in HPV research have positioned it as a valuable tool for exploring the functional properties of viral oncoproteins and their interaction with host cell machinery.
Epitope mapping: Researchers employ the HPV16 E7 86-93 peptide in detailed epitope mapping studies to identify and characterize regions of the E7 protein recognized by T cells or antibodies. By providing a discrete, defined segment of the E7 protein, this peptide allows for the dissection of immune recognition at the molecular level, facilitating the identification of immunodominant regions and their potential role in anti-viral immunity. Such studies are fundamental for elucidating the fine specificity of immune responses to HPV16 infection and for informing the rational design of immunodiagnostic assays.
Immunological assays: The peptide is widely used as a target antigen in ex vivo and in vitro immunological assays, including enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and flow cytometry-based T cell activation assays. Its application enables the detection and quantification of HPV16 E7-specific CD8+ cytotoxic T lymphocyte (CTL) responses in peripheral blood mononuclear cells or other lymphocyte populations. These analyses are critical for evaluating cellular immunity in the context of natural infection, vaccine studies, and immunotherapeutic interventions, providing insights into the magnitude and quality of the antiviral T cell response.
Antigen processing studies: HPV16 E7 86-93 serves as a model substrate for investigating the intracellular processing and presentation of viral antigens by major histocompatibility complex (MHC) class I molecules. By introducing the peptide into antigen-presenting cells or using it as a reference in proteasomal degradation assays, scientists can study the efficiency and pathways of peptide generation, transport, and loading onto MHC molecules. This knowledge advances understanding of antigen presentation dynamics and the factors that influence immune recognition of HPV-infected or transformed cells.
Peptide-based vaccine research: As a well-defined MHC class I-restricted epitope, the HPV16 E7 86-93 fragment is frequently incorporated into experimental vaccine formulations to evaluate its immunogenic potential and capacity to induce antigen-specific T cell responses. Such studies are pivotal in preclinical assessment of peptide-based immunization strategies aimed at eliciting targeted cellular immunity against HPV16-associated malignancies. The use of this peptide supports the optimization of vaccine design by allowing systematic comparison of immune responses to different epitope candidates.
Functional analysis of oncoprotein activity: The peptide is also employed in biochemical and cell-based assays designed to probe the functional attributes of the E7 oncoprotein, particularly regarding its interaction with host cell proteins and its role in cell cycle dysregulation. By serving as a molecular probe or competitor in binding assays, HPV16 E7 86-93 enables researchers to dissect the contribution of specific E7 regions to oncogenic activity, protein-protein interactions, and cellular signaling pathways. These applications are integral to advancing the mechanistic understanding of HPV-induced carcinogenesis and to identifying novel molecular targets for research and intervention.
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More